a rumour alone is enough, to initiate the start of this rocket.
Roche acquired InterMune for $8.3 Billion.
Latest ProMetic Life Sciences Share Price April 21, 2015 : CAD $2,6 / Share.
Market Cap : Prometic LIfe Sciences $1,17 Billion vs. Intermune $8.3 Billion.
Prometic Life Sciences (PLI.TO) could be the next buyout candidate.
Prometic Life Sciences is a Canada-based biopharmaceutical company.
This 'No-Brainer' Stock I believe could double or quadruple in the next time.
COMPANY expects regulatory approval for their orphan drugs.
Use the following website, where you will also find additional information
Please do your reserach on this stock:
These are not in the nature of buy or sell recommendations, but rather rate
the companies from a strategic, forward-looking perspective.